AMANDA WILLIAMS: Open Payments
NPI 1700398351 · PORTLAND, ME. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$562 in 23 payments from 7 companies in 2025. Trend: 2023 $676 · 2024 $497 · 2025 $562
Food & beverage: $562
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 10 | $227 |
| ARS Pharmaceuticals Operations, Inc. | 6 | $153 |
| GENZYME CORPORATION | 3 | $109 |
| Kedrion Biopharma, Inc. | 1 | $24 |
| Novartis Pharmaceuticals Corporation | 1 | $21 |
| GlaxoSmithKline, LLC. | 1 | $14 |
| Regeneron Healthcare Solutions, Inc. | 1 | $14 |
Products named: FASENRA, NEFFY, DUPIXENT, Albuked, Rhapsido, NUCALA.
Industry payments across ME — which companies pay providers there.
